Cutler Investment Counsel’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,549
Closed -$220K 97
2021
Q3
$220K Hold
1,549
0.03% 91
2021
Q2
$242K Sell
1,549
-363
-19% -$58.8K 0.04% 89
2021
Q1
$297K Hold
1,912
0.05% 82
2020
Q4
$286K Hold
1,912
0.05% 81
2020
Q3
$253K Hold
1,912
0.05% 79
2020
Q2
$222K Buy
+1,912
New +$220K 0.05% 83
2020
Q1
Sell
-1,912
Closed -$278K 95
2019
Q4
$278K Hold
1,912
0.06% 79
2019
Q3
$255K Hold
1,912
0.05% 78
2019
Q2
$219K Hold
1,912
0.04% 88
2019
Q1
$237K Buy
+1,912
New +$217K 0.05% 82
2018
Q4
Sell
-1,912
Closed -$244K 95
2018
Q3
$244K Hold
1,912
0.05% 83
2018
Q2
$207K Sell
1,912
-261
-12% -$28.4K 0.04% 88
2018
Q1
$230K Sell
2,173
-262
-11% -$30.4K 0.04% 86
2017
Q4
$285K Hold
2,435
0.06% 78
2017
Q3
$277K Hold
2,435
0.06% 67
2017
Q2
$304K Hold
2,435
0.08% 62
2017
Q1
$289K Hold
2,435
0.07% 64
2016
Q4
$244K Buy
+2,435
New +$261K 0.06% 66

Other funds holding ZBH

Cutler Investment Counsel's ZBH Position: Q4 2021 in Review

Cutler Investment Counsel sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 1,549 shares — an estimated $220K sold.

Cutler Investment Counsel first reported a position in ZBH in Q4 2016 and held it in 18 quarters. The position peaked at $304K in Q2 2017. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Cutler Investment Counsel reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Cutler Investment Counsel sold 1,549 Zimmer Biomet shares in Q4 2021, an estimated $220K.
  • Cutler Investment Counsel first reported a position in Zimmer Biomet in Q4 2016 and held it in 18 quarters.
  • Cutler Investment Counsel's Zimmer Biomet position peaked at $304K in Q2 2017.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Cutler Investment Counsel's 13F filing for Q4 2021, filed 11 Feb 2022.